Change - Announcement of Cessation::Retirement of Independent Director

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
01-Oct-2024 06:45:25
Status
New
Announcement Sub Title
Retirement of Independent Director
Announcement Reference
SG241001OTHR5SK1
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Retirement of Ms. Angeline Tham Xiwen as an Independent Director.

This announcement has been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.

Additional Details

Name Of Person
Angeline Tham Xiwen
Age
42
Is effective date of cessation known?
Yes
If yes, please provide the date
17/10/2024
Detailed Reason (s) for cessation
Ms. Angeline Tham Xiwen will not be seeking re-election due to personal reasons and will retire as a Director of the Company on 17 October 2024, following the conclusion of the Company's Annual General Meeting. Ms. Tham will, upon retirement, cease to be the Chairperson of the Nominating Committee, a member of the Audit Committee and member of the Risk Management Committee.

Based on its enquires, the Sponsor is satisfied that, saved as disclosed in this announcement, there are no other material reasons for the resignation of Ms.Tham as an Independent Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/02/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director, Chairperson of the Nominating Committee, member of the Audit Committee and member of the Risk Management Committee.
Role and responsibilities
Duties of an Independent Director, Chairperson of the Nominating Committee, member of the Audit Committee and member of the Risk Management Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
DBDOYC Inc
Present
Digital Pilipinas Pte Ltd